Literature DB >> 33659256

Cardiac Gq Receptors and Calcineurin Activation Are Not Required for the Hypertrophic Response to Mechanical Left Ventricular Pressure Overload.

Ze-Yan Yu1,2,3, Hutao Gong1, Jianxin Wu1, Yun Dai1, Scott H Kesteven1, Diane Fatkin1,2,3, Boris Martinac1,3, Robert M Graham1,2,3, Michael P Feneley1,2,3.   

Abstract

RATIONALE: Gq-coupled receptors are thought to play a critical role in the induction of left ventricular hypertrophy (LVH) secondary to pressure overload, although mechano-sensitive channel activation by a variety of mechanisms has also been proposed, and the relative importance of calcineurin- and calmodulin kinase II (CaMKII)-dependent hypertrophic pathways remains controversial.
OBJECTIVE: To determine the mechanisms regulating the induction of LVH in response to mechanical pressure overload. METHODS AND
RESULTS: Transgenic mice with cardiac-targeted inhibition of Gq-coupled receptors (GqI mice) and their non-transgenic littermates (NTL) were subjected to neurohumoral stimulation (continuous, subcutaneous angiotensin II (AngII) infusion for 14 days) or mechanical pressure overload (transverse aortic arch constriction (TAC) for 21 days) to induce LVH. Candidate signaling pathway activation was examined. As expected, LVH observed in NTL mice with AngII infusion was attenuated in heterozygous (GqI+/-) mice and absent in homozygous (GqI-/-) mice. In contrast, LVH due to TAC was unaltered by either heterozygous or homozygous Gq inhibition. Gene expression of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and α-skeletal actin (α-SA) was increased 48 h after AngII infusion or TAC in NTL mice; in GqI mice, the increases in ANP, BNP and α-SA in response to AngII were completely absent, as expected, but all three increased after TAC. Increased nuclear translocation of nuclear factor of activated T-cells c4 (NFATc4), indicating calcineurin pathway activation, occurred in NTL mice with AngII infusion but not TAC, and was prevented in GqI mice infused with AngII. Nuclear and cytoplasmic CaMKIIδ levels increased in both NTL and GqI mice after TAC but not AngII infusion, with increased cytoplasmic phospho- and total histone deacetylase 4 (HDAC4) and increased nuclear myocyte enhancer factor 2 (MEF2) levels.
CONCLUSION: Cardiac Gq receptors and calcineurin activation are required for neurohumorally mediated LVH but not for LVH induced by mechanical pressure overload (TAC). Rather, TAC-induced LVH is associated with activation of the CaMKII-HDAC4-MEF2 pathway.
Copyright © 2021 Yu, Gong, Wu, Dai, Kesteven, Fatkin, Martinac, Graham and Feneley.

Entities:  

Keywords:  CaMKIIδ; Gq receptors; calcineurin; neurohumoral stimulation; pressure overload induced hypertrophy

Year:  2021        PMID: 33659256      PMCID: PMC7917224          DOI: 10.3389/fcell.2021.639509

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  65 in total

1.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

Authors:  D D D'Angelo; Y Sakata; J N Lorenz; G P Boivin; R A Walsh; S B Liggett; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  TRPC channels are necessary mediators of pathologic cardiac hypertrophy.

Authors:  Xu Wu; Petra Eder; Baojun Chang; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations.

Authors:  P De Koninck; H Schulman
Journal:  Science       Date:  1998-01-09       Impact factor: 47.728

4.  MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells.

Authors:  Roman Ginnan; Li Yan Sun; John J Schwarz; Harold A Singer
Journal:  Biochem J       Date:  2012-05-15       Impact factor: 3.857

5.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

Review 6.  Calcineurin and beyond: cardiac hypertrophic signaling.

Authors:  J D Molkentin
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

7.  Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface.

Authors:  Jianqin Wei; Shaurya Joshi; Svetlana Speransky; Christopher Crowley; Nimanthi Jayathilaka; Xiao Lei; Yongqing Wu; David Gai; Sumit Jain; Michael Hoosien; Yan Gao; Lin Chen; Nanette H Bishopric
Journal:  JCI Insight       Date:  2017-09-07

8.  TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.

Authors:  Naoya Onohara; Motohiro Nishida; Ryuji Inoue; Hiroyuki Kobayashi; Hideki Sumimoto; Yoji Sato; Yasuo Mori; Taku Nagao; Hitoshi Kurose
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

9.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

10.  ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice.

Authors:  H A Rockman; S P Wachhorst; L Mao; J Ross
Journal:  Am J Physiol       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.